Security key
640979100
Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)
CUSIP: 640979100
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 186,788,806
- Total 13F shares
- 80,333,766
- Share change
- +9,462,792
- Total reported value
- $851,575,296
- Put/Call ratio
- 93%
- Price per share
- $10.60
- Number of holders
- 132
- Value change
- +$93,329,557
- Number of buys
- 73
- Number of sells
- 44
Report period
Q4 2024
Institutions
132
Top holders
10
NMRA full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Neumora Therapeutics, Inc. SEC filings
Neumora Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640979100
Recent filing periods:
Top shareholders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AMGEN INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
35,368,653
|
$423,716,463 | — | 19 Sep 2023 | |
| FMR LLC |
13F
3/4/5
|
Company · Other* |
4.1%
|
7,749,156
|
$102,366,351 | — | 30 Sep 2024 | |
| SOFTBANK GROUP CORP. |
13F
|
Company |
4%
|
7,546,916
|
$99,694,760 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
3.3%
|
6,186,894
|
$81,728,871 | — | 30 Sep 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.8%
|
5,228,333
|
$69,067,000 | — | 30 Sep 2024 | |
| MIC Capital Management UK LLP |
13F
|
Company |
2.4%
|
4,460,700
|
$58,925,848 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
4,377,166
|
$57,822,363 | — | 30 Sep 2024 | |
| ICONIQ Capital, LLC |
13F
|
Company |
1.8%
|
3,398,628
|
$44,895,876 | — | 30 Sep 2024 | |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST |
13F
|
Company |
1.8%
|
3,309,123
|
$43,713,515 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
1.4%
|
2,606,571
|
$34,432,803 | — | 30 Sep 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.1%
|
2,071,450
|
$27,363,855 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,979,847
|
$26,159,035 | — | 30 Sep 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.99%
|
1,849,445
|
$24,431,168 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.96%
|
1,800,000
|
$23,778,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.96%
|
1,790,707
|
$23,655,239 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.8%
|
1,500,000
|
$19,815,000 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.55%
|
1,034,600
|
$13,667,066 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.44%
|
828,101
|
$10,939,214 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
698,255
|
$9,223,949 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
682,383
|
$9,014,279 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.36%
|
676,244
|
$8,932,783 | — | 30 Sep 2024 | |
| Callan Capital, LLC |
13F
|
Company |
0.35%
|
661,194
|
$8,734,373 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.33%
|
625,478
|
$8,264,000 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
0.3%
|
567,428
|
$7,495,724 | — | 30 Sep 2024 | |
| Gosebruch Henry O |
3/4/5
|
President & CEO, Director |
—
mixed-class rows
|
749,793
mixed-class rows
|
$7,065,720 | — | 14 Feb 2024 | |
| SOROS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
508,913
|
$6,722,741 | — | 30 Sep 2024 | |
| Paul L. Berns |
13D/G
|
— |
5.1%
|
8,226,272
|
$6,334,229 | $0 | 31 Dec 2024 | |
| Capital International Investors |
13F
|
Company |
0.25%
|
467,180
|
$6,171,448 | — | 30 Sep 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.23%
|
432,996
|
$5,719,877 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
353,691
|
$4,672,258 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.18%
|
340,021
|
$4,491,677 | — | 30 Sep 2024 | |
| Carol Y. Suh |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
544,674
mixed-class rows
|
$4,488,595 | — | 14 Feb 2024 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
339,671
|
$4,487,055 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.16%
|
307,558
|
$4,062,841 | — | 30 Sep 2024 | |
| Addis & Hill, Inc |
13F
|
Company |
0.16%
|
300,000
|
$3,963,000 | — | 30 Sep 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.13%
|
242,900
|
$3,208,710 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
225,732
|
$2,981,920 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.12%
|
222,877
|
$2,944,205 | — | 30 Sep 2024 | |
| Auour Investments LLC |
13F
|
Company |
0.13%
|
250,000
|
$2,932,500 | — | 30 Sep 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.12%
|
217,879
|
$2,878,182 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
216,431
|
$2,859,054 | — | 30 Sep 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.08%
|
154,019
|
$2,034,591 | — | 30 Sep 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
150,000
|
$1,981,500 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
150,418
|
$1,943,401 | — | 30 Sep 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.07%
|
139,337
|
$1,840,641 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
129,210
|
$1,706,864 | — | 30 Sep 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
118,166
|
$1,560,973 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
111,665
|
$1,475,086 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
0.06%
|
110,000
|
$1,453,100 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.06%
|
109,802
|
$1,450,484 | — | 30 Sep 2024 |
Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) as of Q4 2024
As of 31 Dec 2024,
Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,333,766 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., SOFTBANK GROUP CORP., T. Rowe Price Investment Management, Inc., VANGUARD GROUP INC, MIC Capital Management UK LLP, Siren, L.L.C., Deep Track Capital, LP, Capital International Investors, and WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST.
This page lists
132
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
103
Q4 2024 holders
132
Holder diff
29
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.